ALINITY C TRANSFERRIN
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.·Registered December 27, 2021ELENSAYOTRANSFERRINASEUTILIZAPARALA DETERMINACIÓN CUANTITATIVA DETRANSFERRINA EN SUERO O PLASMAHUMANOSENELALINITYCSYSTEM. AGENTEDEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVOENLABORATORIOSCLÍNICOSY DE GABINETE.
THE TRANSFERRIN ASSAY IS USED FOR THE QUANTITATIVE DETERMINATION OF TRANSFERRIN IN HUMAN SERUM OR PLASMA IN THE LINITYCSYSTEM. DIAGNOSTICAGENTFORUSEINVITRO. FOR EXCLUSIVE USE IN CLINICAL AND CABINET LABORATORIES.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓNCUANTITATIVA DE TRANSFERRINA
- Trade Name (English)
- TEST FOR THE QUANTITATIVE DETERMINATION OF TRANSFERRIN
- Analysis ID
- 2223R2021 SSA
- Registration Date
- December 27, 2021
- Name (Spanish)
- ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ALINITY C TRANSFERRIN (ALINITY C TRANSFERRIN) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2223R2021 SSA and manufactured by ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on December 27, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.